TXMD - TherapeuticsMD, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
38,835
16,099
16,778
19,356
20,143
Cost of Revenue
4,407
2,738
2,637
4,186
4,507
Gross Profit
34,428
13,362
14,141
15,171
15,636
Operating Expenses
Research Development
22,113
27,299
33,853
53,943
72,043
Selling General and Administrative
156,789
115,989
57,703
51,348
28,721
Total Operating Expenses
179,362
143,582
91,769
105,424
100,826
Operating Income or Loss
-144,934
-130,220
-77,629
-90,254
-85,190
Interest Expense
13,811
4,678
-
0
-
Total Other Income/Expenses Net
-7,356
2,281
696
367
96
Income Before Tax
-166,100
-132,617
-76,925
-89,875
-85,077
Income Tax Expense
0
0
0
0
-
Income from Continuing Operations
-166,100
-132,617
-76,925
-89,875
-85,077
Net Income
-166,100
-132,617
-76,925
-89,875
-85,077
Net Income available to common shareholders
-166,100
-132,617
-76,925
-89,875
-85,077
Reported EPS
Basic
-
-0.59
-0.37
-0.46
-0.49
Diluted
-
-0.59
-0.37
-0.46
-0.49
Weighted average shares outstanding
Basic
-
225,026
205,523
196,088
173,174
Diluted
-
225,026
205,523
196,088
173,174
EBITDA
-
-127,645
-77,416
-90,121
-85,128